01
Bilateral relationship
A sending laboratory and performing laboratory review and approve the relationship independently.
Reference & Send-Out Testing
Configure approved bilateral relationships, reference menus, private terms, mappings, specimen custody, turnaround, and performer-authoritative results without creating a separate integration product for every laboratory pair.
Sandbox status
Controlled hosted acceptance has exercised bilateral approval, a reference menu, private terms, a canonical order, accession and turnaround, FINAL results, CORRECTED results, and unrelated-laboratory isolation. Sandbox evidence validates the generic architecture; it does not authorize a real laboratory pair for Production.
Production boundary
No laboratory currently has live R2 Production activity. Activation requires a real bilateral pilot and separate technical, clinical, commercial, security, and operational approval. Missing authority, mappings, terms, or readiness evidence must continue to fail closed.
Relationship workflow
01
A sending laboratory and performing laboratory review and approve the relationship independently.
02
Approved tests, specimen requirements, turnaround targets, pricing context, and relationship terms are scoped to the laboratory pair.
03
Sender requests are explicitly mapped to performer orderables, specimen rules, native codes, and result expectations before execution.
04
The sender and performer operate against one canonical order with accession, specimen-custody, status, and turnaround context.
05
The performing laboratory remains authoritative for FINAL and CORRECTED results, with provenance and version history preserved.
What the product supports
The performing laboratory remains authoritative for testing and official results. The sending laboratory retains its customer and operational relationship. Solia provides the governed relationship, canonical workflow, and shared operating visibility.
Controlled activation
Sandbox configuration and synthetic acceptance are available for evaluation. A real laboratory relationship remains subject to bilateral agreement, mappings, validation, and explicit Production authorization.